ARCHIVES

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Farber Grant Probe Misses Real Story

July 8, 1977

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1

March 4, 1988

New Phone Number For Customer Service For The Cancer Letter

February 6, 1998

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995